InnoCan Pharma

A pharmaceutical technology company developing innovative drug delivery platforms and products using cannabinoids.

Health Tech & Life Sciences
public
Public Herzliya, Israel Founded 2017
Last updated 2026-07-26
Total raised
$14.3M
Last: Debt Financing 2026-03
Stage
Public
Founded
2017
Headcount
11
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences

About

InnoCan Pharma is a pharmaceutical technology company that operates under two main segments: Pharmaceuticals and Consumer Wellness. In the Pharmaceuticals segment, InnoCan focuses on developing innovative drug delivery platform technologies comprised of cannabinoid science to treat various conditions and improve patients' quality of life. This segment involves two drug delivery technologies: LPT CBD-loaded liposome platform and CLX CBD-loaded exosomes platform. In the consumer wellness segment, InnoCan develops and markets a wide portfolio of innovative self-care products to promote a healthier lifestyle.

Funding history · 12 rounds · $14.3M total

2025-03
PIPE Undisclosed
2025-02
PIPE $1.0M
★ Tamar Innovest
2024-12
PIPE Undisclosed
2024-07
PIPE $811K
2024-02
PIPE $1.9M
2023-07
PIPE $1.4M
2021-09
PIPE $6.6M
2021-07
Follow-on PO Undisclosed
2020-11
PIPE $1.8M
2020-05
Follow-on PO Undisclosed
2019-08
Follow-on PO Undisclosed
2018-07
Undisclosed Round $850K
★ PipelBiz

Headcount over time

From 4 (2019-01) to 14 (2025-12) · +10 (+250%) · 13 points · source: Finder history + radar grounding
150 2019-01 2025-12

Q&A

What is InnoCan Pharma's primary focus?
InnoCan Pharma is a pharmaceutical technology company developing innovative drug delivery platforms and products using cannabinoids, operating in both Pharmaceutical and Consumer Wellness segments.
When was InnoCan Pharma founded and where is its headquarters?
InnoCan Pharma was founded in October 2017 and is headquartered in Herzliya, Israel.
What is the current employee count for InnoCan Pharma?
InnoCan Pharma has 11-50 employees.
What was InnoCan Pharma's most recent funding round?
In March 2026, InnoCan Pharma secured Debt Financing with Tamar Innovest Limited.
What was the total amount raised by InnoCan Pharma to date?
InnoCan Pharma has raised a total of $20,120,000 USD.
What is InnoCan Pharma's status as a company?
InnoCan Pharma is a public company.
What are the key drug delivery technologies InnoCan Pharma is developing?
InnoCan Pharma is developing two drug delivery technologies: LPT CBD-loaded liposome platform and CLX CBD-loaded exosomes platform.
Who are the founders of InnoCan Pharma?
The founders of InnoCan Pharma are Ron Mayron, Iris Bincovich, Nir Avram, and Yoram Drucker.

Team · 14

Ron Mayron
Founder · Founder & Executive Chairman
Iris Bincovich
Founder · Founder & CEO
Nir Avram
Founder · Founder & CTO
Yoram Drucker
Founder · Founder
Roni Kamhi
COO, CEO of B.I. Sky Global LTD & Director
Nelson Halpern
CFO
Eyal Kalo
VP of Research and Development
Eyal Flom
Company Secretary, General Counsel & Director
Peter David Bloch
Independent Director
Ralph C. L. Bossino
Independent Director
Joshua A. Lintern
Independent Director
Yechezkel Barenholz
Chairman of Scientific Advisory Board
Joseph V. Pergolizzi
Member of Scientific Advisory Board
Antonio M. Benitz
Member of Scientific Advisory Board

Sectors & technology

Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2B2CB2CB2B

Highlights

Patents

Tags

diabetesdrug-deliverypharmaceuticalstherapeuticscannabispatientstopical-treatmentdermatologypain-reliefpatent-pendingwellnesspharma-companieswomen-healthalzheimers-diseasetreatmentsepilepsyecommercecell-therapymedical-cannabisinhalationcosmetics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteinnocanpharma.com
LinkedInlinkedin.com/company/28636009

Identifiers & details

Legal nameInnocan Pharma Corporation
Founded2017-10
Employees (exact)11

Radar intelligence

Patents

EPO10

Web history (Wayback)

Domaininnocanpharma.com

Certificate / subdomain footprint

Subdomains3

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515732881
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2017-10-18
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2026
Active charges / liens0
Registry events2 — annual_report (2)
Registered addressאריק איינשטיין 3 הרצליה

Recent registry events

DateEvent
2026-01-14דו~ח שנתי-הוספת דירקטור
2026-01-14דו~ח שנתי-הסרת דירקטור